| Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation S Matoba, Y Liu, F Lu, KA Iwabuchi, L Shen, A Inoue, Y Zhang Cell 159 (4), 884-895, 2014 | 501 | 2014 |
| Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping P Gee, MSY Lung, Y Okuzaki, N Sasakawa, T Iguchi, Y Makita, H Hozumi, ... Nature communications 11 (1), 1334, 2020 | 284 | 2020 |
| High-resolution analysis with novel cell-surface markers identifies routes to iPS cells J O’Malley, S Skylaki, KA Iwabuchi, E Chantzoura, T Ruetz, A Johnsson, ... Nature 499 (7456), 88-91, 2013 | 192 | 2013 |
| Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice E Kenjo, H Hozumi, Y Makita, KA Iwabuchi, N Fujimoto, S Matsumoto, ... Nature communications 12 (1), 7101, 2021 | 156 | 2021 |
| Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells M Imamura, K Miura, K Iwabuchi, T Ichisaka, M Nakagawa, J Lee, ... BMC developmental biology 6, 1-16, 2006 | 147 | 2006 |
| Loss of H3K27me3 imprinting in somatic cell nuclear transfer embryos disrupts post-implantation development S Matoba, H Wang, L Jiang, F Lu, KA Iwabuchi, X Wu, K Inoue, L Yang, ... Cell stem cell 23 (3), 343-354. e5, 2018 | 139 | 2018 |
| Restoration of dystrophin protein expression by exon skipping utilizing CRISPR-Cas9 in myoblasts derived from DMD patient iPS cells M Ifuku, KA Iwabuchi, M Tanaka, MSY Lung, A Hotta Exon Skipping and Inclusion Therapies: Methods and Protocols, 191-217, 2018 | 24 | 2018 |
| ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSCGeneration, but it is dispensable for the maintenance and induction of pluripotency KA Iwabuchi, T Yamakawa, Y Sato, T Ichisaka, K Takahashi, K Okita, ... PLoS One 6 (5), e20461, 2011 | 23 | 2011 |
| Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity A Gravina, G Tediashvili, Y Zheng, KA Iwabuchi, SM Peyrot, SZ Roodsari, ... Cell Stem Cell 30 (11), 1538-1548. e4, 2023 | 7 | 2023 |
| Generation of induced pluripotent stem cells from human melanoma tumor-infiltrating lymphocytes H Saito, K Iwabuchi, N Fusaki, F Ito Journal of visualized experiments: JoVE, 2016 | 7 | 2016 |
| Embryonic Stem Cell Proliferation Stimulated By Altered Anabolic Metabolism From Glucose Transporter 2-Transported Glucosamine. MRL Jin Hyuk Jung, Kumiko Iwabuchi, Zhihong Yang Scientific Reports 6 (28452), 2016 | 6 | 2016 |
| Composition for modifying target gene A Hotta, M Ifuku, N Fujimoto, K Iwabuchi, E Kenjo, Y Makita, R Ochiai US Patent 12,031,130, 2024 | 1 | 2024 |
| New marker for detection of induced pluripotent stem cell S Yamanaka, K Iwabuchi WO2010137744, 2010 | 1 | 2010 |
| Hormone and nuclear receptor activations are required for cardiomyocyte maturation N Chanthra, RE Ahmed, T Anzai, T Tokuyama, KA Iwabuchi, Y Hanazono, ... Journal of Molecular and Cellular Cardiology 173, S182, 2022 | | 2022 |
| COMPOSITION FOR MODIFYING A GOAL GENE A Hotta, M Ifuku, N Fujimoto, K Iwabuchi, E KENJO, Y MAKITA, R Ochiai | | 2021 |
| Comprehensive profiling of TCR and BCR repertoire of infiltrated lymphocytes in the mouse injured skeletal muscle KA Iwabuchi, N Sasakawa, A Hotta The Journal of Immunology 204 (1_Supplement), 86.6-86.6, 2020 | | 2020 |
| Nanomembrane-Derived Extracellular Vesicles for the Delivery of Crispr-Cas9/Grna for Therapeutic Exon Skipping in Duchenne Muscular Dystrophy A Hotta, P Gee, MSY Lung, Y Okuzaki, N Sasakawa, T Iguchi, Y Makita, ... MOLECULAR THERAPY 28 (4), 565-565, 2020 | | 2020 |
| ゲノム編集技術とその応用の現状 岩渕久美子， 堀田秋津 血液フロンティア= Hematology frontier 28 (3), 343-352, 2018 | | 2018 |
| Identifying and Overcoming an Epigenetic Barrier for SCNT Reprogramming Y Zhang, S Matoba, Y Liu, F Lu, K Iwabuchi, L Shen, A Inoue International Journal of Fertility & Sterility 9, 15, 2015 | | 2015 |
| ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSC generation, but it is dispensable for the pluripotency K Iwabuchi Kyoto University, 2011 | | 2011 |
Akitsu Hotta, Ph.D.Center for iPS Cell Research & Application (CiRA), Kyoto University在 cira.kyoto-u.ac.jp 的电子邮件经过验证
